Sino Biopharmaceutical | 1177 - Ordinary Share Capital


Sino Biopharmaceutical reported CNY17.89B in Ordinary Share Capital for its fiscal semester ending in June of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Jiangsu Hengrui CNY 6.64B 0 Mar/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 260.32M 333K Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025